Tata Chemicals Financial Results

Tata Chemicals Other Announcement

Tata Chemicals disclosed an ESG score of 68.74 from Niche Ninety Nine, an unengaged provider. The score uses public FY2025-26 data; no operational impact.

Tata Chemicals Board Meeting Date

Tata Chemicals will hold a board meeting on 7 November 2026 to approve half-year results. Trading window stays closed until 48 hours after publication.

Tata Chemicals Legal & Regulatory

Tata Chemicals provided a Regulation 30 update on its Kenyan subsidiary TCML. The Kenyan High Court ruled it lacks jurisdiction over the dispute with the Mining Ministry, which is now under government technical review.

Tata Chemicals Legal & Regulatory

Tata Chemicals Limited was directed by the Mumbai Centre for International Arbitration to pay ₹1 Crore in a dispute with Allied Silica Limited. This follows a significantly larger ₹908 Crore claim initially filed against the company.

Value

₹1.00 Cr

Tata Chemicals Legal & Regulatory

Tata Chemicals won an arbitration as the MCIA rejected a ₹908 crore claim by Allied Silica Limited. The company is directed to pay only ₹1 crore plus interest.

Value

₹909.0 Cr

Tata Chemicals Debt & Borrowing

Tata Chemicals filed its half-yearly statement of outstanding debt securities for September 30, 2026. Two listed NCDs with ISINs, coupons, and maturities are reported.

Systematic Industries H1 FY27 Results: Net Profit ₹12.8 Cr, Up 37.6% YoY

Systematic Industries Ltd reported revenue from operations of ₹311.4 Cr (+22.7% YoY) and net profit of ₹12.8 Cr (+37.6% YoY) for H1 FY27.

Key figure

Net profit ₹12.8 Cr · +37.6% YoY

Adarsh Plant Protect Q2 FY27 Results: Net Loss of ₹0.2 Cr

Adarsh Plant Protect approved unaudited standalone results for quarter and half-year ended 30 September 2026. Half-year showed a pre-tax loss and lower revenue than last year.

Key figure

Net loss ₹0.2 Cr

Nephrocare Health Services Q2 FY27 Results: Turns Profitable, Net Profit ₹33.5 Cr

Nephrocare Health Services Ltd reported revenue from operations of ₹303.4 Cr (+23.5% YoY) and net profit of ₹33.5 Cr for Q2 FY27.

Key figure

Net profit ₹33.5 Cr

Sandur Manganese & Iron Ores Q2 FY27 Results: Net Profit ₹261.2 Cr, Up 88.0% YoY

Sandur Manganese & Iron Ores Ltd reported revenue from operations of ₹1,506 Cr (+22.2% YoY) and net profit of ₹261.2 Cr (+88.0% YoY) for Q2 FY27.

Key figure

Net profit ₹261.2 Cr · +88.0% YoY

Lords Chloro Alkali Q2 FY27 Results: Net Profit ₹9 Cr, Up 0.0% YoY

Lords Chloro Alkali's board approved unaudited results for the quarter and half year ended September 30, 2026. Statutory auditors issued a limited review report on the results.

Key figure

Net profit ₹9 Cr · +0.0% YoY

Jenburkt Pharmaceuticals Q2 FY27 Results: Net Profit ₹10.2 Cr, Up 0.0% YoY

Jenburkt Pharmaceuticals posted Q2 revenue of Rs. 4,831.82 lakhs and PAT of Rs. 1,020.94 lakhs. Results were approved on 3 November 2026.

Key figure

Net profit ₹10.2 Cr · +0.0% YoY